Next Article in Journal
Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma
Next Article in Special Issue
Generation and Next-Generation Sequencing-Based Characterization of a Large Human Combinatorial Antibody Library
Previous Article in Journal
Sodium-Glucose Cotransporter-2 Inhibitors—Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials
Previous Article in Special Issue
omicsGAT: Graph Attention Network for Cancer Subtype Analyses
 
 
Review
Peer-Review Record

Influence of the Microbiome Metagenomics and Epigenomics on Gastric Cancer

Int. J. Mol. Sci. 2022, 23(22), 13750; https://doi.org/10.3390/ijms232213750
by Precious Mathebela 1, Botle Precious Damane 1,*, Thanyani Victor Mulaudzi 1, Zilungile Lynette Mkhize-Khwitshana 2,3, Guy Roger Gaudji 4 and Zodwa Dlamini 5,*
Reviewer 1:
Reviewer 2:
Int. J. Mol. Sci. 2022, 23(22), 13750; https://doi.org/10.3390/ijms232213750
Submission received: 3 October 2022 / Revised: 1 November 2022 / Accepted: 4 November 2022 / Published: 9 November 2022
(This article belongs to the Special Issue From Omics to Therapeutic Targets in Cancer)

Round 1

Reviewer 1 Report

A valuable and intriguing paper, but lacking of consideration of al least one crucial and non-negligible topic: no consideration of the relationship between gastric microbioma and nitrosamines.

About this item, e.g. see:

- Engstrand L, Graham DY, 2020; Song P, Wu L, Guan W, 2015; 

- under an historical perspective, Schmahl D, 1978; Issemberg P, 1976.

In my humble opinion, useful some attention to the relationship between asbestos adn gastric cancer (e.g. see Fang YJ et al Increased risk of gastric cancer in asbestos-exposed workers. Int J Environ Res Pb Health 2021).        

Author Response

Dear Reviewer,

Thank you for the time spent reviewing the manuscript.

Kindly see the attached response letter.

Author Response File: Author Response.pdf

Reviewer 2 Report

In the present study, authors want to explore the role of microbiome in Gastric Cancer, and this is an interesting topic, however, it seems that authors fail to reach this purpose. Below is my main commands:

 

The language is good, and the paper reads smoothly. But the title authors used is “Influence of the Microbiome Metagenomics and Epigenomics  on Gastric Cancer”, so authors should mainly discuss the role of microbiome in the occurrence, development, treatment and prognosis of Gastric Cancer, and how to take use of this in the treatments of Gastric Cancer. But in the whole paper, authors mostly listed the known knowledge on the GC and its mechanisms, which well written, but lack novelty and and is boring.

So, this paper need a major revision to deeply explore the role of microbiome (stomach or gut) on the GC, and its potential application in clinic trails.

Author Response

Dear Reviewer

Thank you for the time spent reading the manuscript.

Kindly see the attached response letter.

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

The paper has been adequately improved; it doesn't introduces deeply novel approaches to the topic, but provides a clear and useful overall look to the reader.  

Reviewer 2 Report

Acceptable

Back to TopTop